eliminating the system's transcutaneous wire will lessen the false positive rate and eliminate the risk of vessel compromise upon probe withdrawal. We present our development and testing of a prototype implantable wireless Doppler device to monitor vascular blood flow.
Prototype development
A continuous-wave Doppler device was made from commercial off-the-shelf components (Fig 1) . All electronics fit on a 32mm diameter circular electronic board. Two 20-MHz piezoelectric transducers were mounted in a 5mm diameter silicone cuff. A 400mAh lithium-ion battery was outfitted to the device allowing 3 hours of continuous and 3.5 weeks of intermittent blood flow detection. The device was encased in a waterproof silicon capsule. The device was wirelessly activated using a transceiver that also received wirelessly transmitted blood flow data. The wireless link operates at 915-MHz (Industrial, Scientific, and Medical (ISM) standard radio band), with an approximately 20 feet range, using frequency modulation (FM) digital signal transmission. Wirelessly received signals were converted to audiovisual signal for computer display. To address potential electrical interference, we used our previously developed algorithm to mitigate lost data [13] , an inevitability with wireless channels in the hospital setting.
In vitro testing
The silicon cuff of the Doppler device was affixed to distensible plastic tubing connected to a syringe. A blood mimicking fluid (Blue Phantom, Sarasota, FL) was pumped manually to simulate pulsatile blood flow. The device successfully detected the Doppler shifted signals and wirelessly transmitted to the receiver (see video, supplemental digital content). 
In vivo testing in swine femoral vein model

Statistics
Parametric data were analyzed using one-way ANOVA with Bonferroni's post-hoc analysis. P ≤ 0.05 was considered significant.
DISCUSSION
Clinical evaluation of free flaps by an experienced clinician has stood the test of time and proved to be the irreplaceable gold standard. However, an experienced examiner may not be always available. Furthermore, it is difficult to clinically monitor completely buried free flaps, skin grafted muscle flaps and flaps with small skin paddles.
To overcome these shortcomings numerous devices have been developed. The implantable Doppler probe [11] enables continuous monitoring of blood flow. This probe is connected to an external monitor via a wire that is simply pulled at the conclusion of the monitoring period, leaving the silicon cuff attached to the vessel.
Several studies have demonstrated its efficacy in monitoring free flaps [14] [15] [16] and improved salvage rates following microvascular compromise [17, 18] . The wired implantable Doppler, purposefully designed to allow wire/sensor removal with a gentle tug, has an inherently high risk of false positive alerts due to due to inadvertent probe disengagement. . Additionally, the sensor may occasionally be too adherent to the silicon cuff, such that wire withdrawal creates a kink or injury to the vessel. These design weaknesses are the impetus behind the development of a wireless system.
To our knowledge, the current prototype is the first implantable wireless Doppler flow monitor of its kind, designed to monitor free flap perfusion. The device promptly and unambiguously distinguished between flow and occlusion. With the current prototype, Doppler shifted signals were successfully transmitted via Federal Communications Commission (FCC) approved ISM 915Mhz wireless radio band without significant interference or ambiguity.
The current prototype, designed from off-the-shelf, commercially available components, is too large to be used clinically as an implanted device. The future generation of this device will use ultra-small integrated circuit microchip technology, allowing miniaturization to 1x1 x0.5mm. While our prototype uses a 400mAh lithium battery that provides 3.5 weeks of intermittent blood flow detection, miniaturization will significantly reduce power requirements. This reduction facilitates batteryless, wireless transcorporeal inductive powering with no practical limits on lifetime of use.
CONCLUSION
We have created the first entirely implantable wireless Doppler device that distinguishes clearly between venous blood flow and occlusion. The future generation of this device will be miniaturized, batteryless, and incorporated into an anastomotic coupler. Miniaturization will also enable implementation of the technology into a new generation of vascular stents and other novel implantable devices that have the potential to improve care and lower health care costs. 
